Insider · CIK 0001726334
Pontifax Management 4 G.P. (2015) Ltd.
owner
Files at LBRX (LB PHARMACEUTICALS INC). First filing Sep 16, 2025, latest Sep 16, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$15M bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 57Moderate | LB PHARMACEUTICALS INC | $15M 1,000,000 shares | +243% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 12, 2025 | LBRX LB PHARMACEUTICALS INC | CConversion Common Stockindirect: See footnote | +411,681 | - | - | 411,681 | Sep 16, 2025 |
| Sep 12, 2025 | LBRX LB PHARMACEUTICALS INC | POpen-market purchase Common Stockindirect: See footnote | +1,000,000 | $15.00 | $15M | 1,411,681 | Sep 16, 2025 |
| Sep 12, 2025 | LBRX LB PHARMACEUTICALS INC | CConversion Series C Preferred Stockderivativeindirect: See footnotes | -10,000,000 | - | - | 0 | Sep 16, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.